Home
>
National Drug Code (NDC)
>
Lidocaine Hydrochloride and Hydrocortisone Acetate
Lidocaine Hydrochloride and Hydrocortisone Acetate - 13925-160-03 - (Lidocaine Hydrochloride and Hydrocortisone Acetate)
Drug Information of Lidocaine Hydrochloride and Hydrocortisone Acetate
| Product NDC: | 13925-160 |
| Proprietary Name: | Lidocaine Hydrochloride and Hydrocortisone Acetate |
| Non Proprietary Name: | Lidocaine Hydrochloride and Hydrocortisone Acetate |
| Active Ingredient(s): | 5; 30 mg/g; mg/g & nbsp; Lidocaine Hydrochloride and Hydrocortisone Acetate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lidocaine Hydrochloride and Hydrocortisone Acetate
| Product NDC: | 13925-160 |
| Labeler Name: | Seton Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20110617 |
Package Information of Lidocaine Hydrochloride and Hydrocortisone Acetate
| Package NDC: | 13925-160-03 |
| Package Description: | 1 TUBE in 1 CARTON (13925-160-03) > 85 g in 1 TUBE |
NDC Information of Lidocaine Hydrochloride and Hydrocortisone Acetate
| NDC Code | 13925-160-03 |
| Proprietary Name | Lidocaine Hydrochloride and Hydrocortisone Acetate |
| Package Description | 1 TUBE in 1 CARTON (13925-160-03) > 85 g in 1 TUBE |
| Product NDC | 13925-160 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Lidocaine Hydrochloride and Hydrocortisone Acetate |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20110617 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Seton Pharmaceuticals |
| Substance Name | HYDROCORTISONE ACETATE; LIDOCAINE HYDROCHLORIDE |
| Strength Number | 5; 30 |
| Strength Unit | mg/g; mg/g |
| Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
